Protein tyrosine phosphatases as therapeutic targets

Handbook of Experimental Pharmacology

Volumn 167, Issue , 2005, Pages 191-214

  Cheng, A ^a   Uetani, N ^a   Lampron, C ^a   Tremblay, M L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Microbial phosphatase; Protein tyrosine phosphatase; Signal transduction; Therapeutic targets; Tyrosine phosphorylation

Indexed keywords

EID: 79959890638     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-26670-4_8     Document Type: Article

References (139)

1. Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Moller NP (2001) Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol 21:7117-36
2. Angers-Loustau A, Cote JF, Charest A, Dowbenko D, Spencer S, Lasky LA, Tremblay ML (1999) Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts. J Cell Biol 144:1019-31
3. Arregui CO, Balsamo J, Lilien J (1998) Impaired integrin-mediated adhesion and signaling in fibroblasts expressing a dominant-negative mutant PTP1B [published erratum appears in J Cell Biol 1998 Dec 14;143(6):1761]. J Cell Biol 143:861-73
4. Barford D (1999) Colworth Medal Lecture. Structural studies of reversible protein phosphorylation and protein phosphatases. Biochem Soc Trans 27:751-766
5. Barford D (2001) The mechanism of protein kinase regulation by protein phosphatases. Biochem Soc Trans 29:385-391
6. Bjorge JD, Pang A, Fujita DJ (2000) Identification of PTP1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines. J Biol Chem
7. Blanchette J, Racette N, Faure R, Siminovitch KA, Olivier M (1999) Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-Triggered JAK2 activation. Eur J Immunol 29:3737-44
8. Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411:355-65
9. Bottini N, Stefanini L, Williams S, Alonso A, Jascur T, Abraham RT, Couture C, Mustelin T (2002) Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J Biol Chem 277:24220-24224
10. Broggini M, Buraggi G, Brenna A, Riva L, Codegoni AM, Torri V, Lissoni AA, Mangioni C, D-Incalci M (2000) Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients. Anticancer Res 20:4835-40
11. Brown-Shimer S, Johnson KA, Lawrence JB, Johnson C, Bruskin A, Green NR, Hill DE (1990) Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B. Proc Natl Acad Sci U S A 87:5148-52
12. Byth KF, Conroy LA, Howlett S, Smith AJ, May J, Alexander DR, Holmes N (1996) CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J Exp Med 183:1707-1718
13. Cangi MG, Cukor B, Soung P, Signoretti S, Moreira GJ, Ranashinge M (2000) Role of the Cdc25A phosphatase in human breast cancer. J Clin Invest 106:753-761
14. Caselli A, Camici G, Manao G, Moneti G, Pazzagli L, Cappugi G (1994) Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatases. J Biol Chem 269:24878-24882
15. Caselli A, Marzocchini R, Camici G, Manao G, Moneti G, Pieraccini G (1998) The inactivation mechanism of low molecular weight phosphotyrosine protein phosphatase by H2O2. J Biol Chem 273:32554-32560
16. Cates CA, Michael RL, Stayrook KR, Harvey KA, Burke YD, Randall SK, Crowell PL, Crowell DN (1996) Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett 110:49-55
17. Chen MS, Hurov J, White LS, Woodford-Thomas T, Piwnica-Worms H (2001) Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase. Mol Cell Biol 21:3853-61
18. Cheng A, Bal GS, Kennedy BP, Tremblay ML (2001) Attenuation of adhesion-dependent signaling and cell spreading in transformed fibroblasts lacking protein tyrosine phosphatase-1B. J Biol Chem 276:25848-55
19. Cheng A, Dube N, Gu F, Tremblay ML (2002a) Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur J Biochem 269:1050-1059
20. Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ, Kennedy BP, Tremblay ML (2002b) Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2:497-503
21. Chiarugi P, Cirri P, Raugei G, Camici G, Dolfi F, Berti A, Ramponi G (1995) PDGF receptor as a specific in vivo target for low M(r) phosphotyrosine protein phosphatase. FEBS Lett 372:49-53
22. Chiarugi P, Cirri P, Taddei L, Giannoni E, Camici G, Manao G, Raugei G, Ramponi G (2000) The low M(r) protein-Tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. J Biol Chem 275:4640-6
23. Cook WS, Unger RH (2002) Protein tyrosine phosphatase 1B: A potential leptin resistance factor of obesity. Dev Cell 2:385-7
24. Cote JF, Chung PL, Theberge JF, Halle M, Spencer S, Lasky LA, Tremblay ML (2002) PSTPIP is a substrate of PTP-PEST and serves as a scaffold guiding PTP-PEST toward a specific dephosphorylation of WASP. J Biol Chem 277:2973-86
25. Countouriotis A, Moore TB, Sakamoto KM (2002) Cell surface antigen and molecular targeting in the treatment of hematologic malignancies. Stem Cells 20:215-29
26. Davidson D, Veillette A (2001) PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. Embo J 20:3414-26
27. den Hertog J, Pals CE, Peppelenbosch MP, Tertoolen LG, de Laat SW, Kruijer W (1993) Receptor protein tyrosine phosphatase alpha activates pp60c-src and is involved in neuronal differentiation. Embo J 12:3789-98
28. Deuel TF, Zhang N, Yeh H-J, Silos-Santiago I, Wang Z-Y (2002) Pleitrophin: A cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 397:162-171
29. Di Paola R, Frittitta L, Miscio G, Bozzali M, Baratta R, Centra M, Spampinato D, Santagati MG, Ercolino T, Cisternino C, Soccio T, Mastroianno S, Tassi V, Almgren P, Pizzuti A, Vigneri R, Trischitta V (2002) A variation in 3-UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 70:806-12
30. Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, Pizzuti A, Dallapiccola B (2002) Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 71:389-394
31. Draetta G, Eckstein J (1997) Cdc25 protein phosphatases in cell proliferation. Biochim Biophys Acta 1332:M53-M63
32. Echwald SM, Bach H, Vestergaard H, Richelsen B, Kristensen K, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O (2002) A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes 51:1-6
33. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP (1999a) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene [see comments]. Science 283:1544-8
34. Elchebly M, Wagner J, Kennedy TE, Lanctot C, Michaliszyn E, Itie A, Drouin J, Tremblay ML (1999b) Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma. Nat Genet 21:330-3
35. Fallman M, Deleuil F, McGee K (2002) Resistance to phagocytosis by Yersinia. Int J Med Microbiol 291:501-9
36. Fecteau S, Basadonna GP, Freitas A, Ariyan C, Sayegh MH, Rothstein DM (2001) CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol 2:58-63
37. Feng GS (1999) Shp-2 tyrosine phosphatase: Signaling one cell or many. Exp Cell Res 253:47-54
38. Finlay BB, Cossart P (1997) Exploitation of mammalian host cell functions by bacterial pathogens. Science 276:718-725
39. Forsell PA, Boie Y, Montalibet J, Collins S, Kennedy BP (2000) Genomic characterization of the human and mouse protein tyrosine phosphatase-1B genes. Gene 260:145-53
40. Fortin JF, Barbeau B, Robichaud GA, Pare ME, Lemieux AM, Tremblay MJ (2001) Regulation of nuclear factor of activated T cells by phosphotyrosyl- specific phosphatase activity: A positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1. Blood 97:2390-400
41. Frangioni JV, Oda A, Smith M, Salzman EW, Neel BG (1993) Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets. Embo J 12:4843-56
42. Fujikawa A, Shirasaka D, Yamamoto S, Ota H, Yahiro K, Fukada M, Shintani T, Wada A, Aoyama N, Hirayama T, Fukamachi H, Noda M (2003) Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet 33:375-81
43. Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M, Beach D (1995) CDC25 phosphatases as potential human oncogenes. Science 269:1575-1577
44. Galaktionov K, Chen X, Beach D (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517
45. Galic S, Klingler-Hoffmann M, Fodero-Tavoletti MT, Puryer MA, Meng TC, Tonks NK, Tiganis T (2003) Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol Cell Biol 23:2096-108
46. Ganesh S, Delgado-Escueta AV, Sakamoto T, Avila MR, Machado-Salas J, Hoshii Y, Akagi T, Gomi H, Suzuki T, Amano K, Agarwala KL, Hasegawa Y, Bai DS, Ishihara T, Hashikawa T, Itohara S, Cornford EM, Niki H, Yamakawa K (2002) Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet 11:1251-1262
47. Garton AJ, Tonks NK (1999) Regulation of fibroblast motility by the protein tyrosine phosphatase PTP-PEST. J Biol Chem 274:3811-8
48. Gil-Henn H, Elson A (2003) Tyrosine phosphatase-epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells. J Biol Chem 278:15579-86
49. Gil-Henn H, Volohonsky G, Elson A (2001) Regulation of protein-Tyrosine phosphatases alpha and epsilon by calpain-mediated proteolytic cleavage. J Biol Chem 276:31772-31779
50. Gray CH, Good VM, Tonks NK, Barford D (2003) The structure of the cell cycle protein Cdc14 reveals a proline-directed protein phosphatase. Embo J 22:3524-35
51. Gu F, Dube N, Kim JW, Cheng A, Ibarra-Sanchez M, de J, Tremblay ML, Boisclair YR (2003) Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling. Mol Cell Biol 23:3753-62
52. Gu M, Majerus PW (1996) The properties of the protein tyrosine phosphatase PTPMEG. J Biol Chem 271:27751-27759
53. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M (2002) SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295:683-686
54. Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE (1998) Crystal structure of the tyrosine phosphatase SHP-2. Cell 92:441-450
55. Johnson KG, Van Vactor D (2003) Receptor protein tyrosine phosphatases in nervous system development. Physiol Rev 83:1-24
56. Johnson TO, Ermolieff J, Jirousek MR (2002) Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov 1:696-709
57. Kar S, Carr BI (2000) Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitamin. J Cell Physiol 185:386-93
58. Kar S, Wang M, Wilcox CS, Carr BI (2003) Antitumor and anticarcinogenic actions of Cpd 5: A new class of protein phosphatase inhibitor. Carcinogenesis 24:411-6
59. Keyse SM (2000) Protein phosphatases and the regulation of mitogen-Activated protein kinase signalling. Curr Opin Cell Biol 12:186-92
60. Kikawa KD, Vidale DR, Van Etten RL, Kinch MS (2002) Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation. J Biol Chem 277:39274-9
61. Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Wakeham A, Timms E, Pfeffer K, Ohashi PS, Thomas ML, et al (1993) Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 74:143-156
62. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB (2000a) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-Tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479-5489
63. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB (2000b) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-Tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479-89
64. Ko S, Jaeger MD, Dahlke MH, Nakajima Y, Schlitt HJ (2002) Manipulation of CD45 antigen in transplantation tolerance. Curr Mol Med 2:249-255
65. Kolmodin K, Aqvist J (2001) The catalytic mechanism of protein tyrosine phosphatases revisited. FEBS Lett 498:208-213
66. Kung C, Pingel JT, Heikinheimo M, Klemola T, Varkila K, Yoo LI, Vuopala K, Poyhonen M, Uhari M, Rogers M, Speck SH, Chatila T, Thomas ML (2000) Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 6:343-345
67. Lazarovits AI, Poppema S, Zhang Z, Khandaker M, Le Feuvre CE, Singhal SK, Garcia BM, Ogasa N, Jevnikar AM, White MH, Singh G, Stiller CR, Zhong RZ (1996) Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 380:717-20
68. Lazo JS, Nemoto K, Pestell KE, Cooley K, Southwick EC, Mitchell DA, Furey W, Gussio R, Zaharevitz DW, Joo B, Wipf P (2002) Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors. Mol Pharmacol 61:720-728
69. Lee SW, Reimer CL, Fang L, Iruela-Arispe ML, Aaronson SA (2000) Overexpression of kinase-Associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression. Mol Cell Biol 20:1723-1732
70. Legius E, Schrander-Stumpel C, Schollen E, Pulles-Heintzberger C, Gewillig M, Fryns JP (2002) PTPN11 mutations in LEOPARD syndrome. J Med Genet 39:571-574
71. Lembertas AV, Perusse L, Chagnon YC, Fisler JS, Warden CH, Purcell-Huynh DA, Dionne FT, Gagnon J, Nadeau A, Lusis AJ, Bouchard C (1997) Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 100:1240-7
72. Li L, Dixon JE (2000) Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases. Semin Immunol 12:75-84
73. Liang F, Huang Z, Lee SY, Liang J, Ivanov MI, Alonso A, Bliska JB, Lawrence DS, Mustelin T, Zhang ZY (2003) Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plague. J Biol Chem
74. Lyon MA, Ducruet AP, Wipf P, Lazo JS (2002) Dual-specificity phosphatases as targets for antineoplastic agents. Nat Rev Drug Discov 1:961-76
75. Maehama T, Taylor GS, Dixon JE (2001) PTEN and myotubularin: Novel phosphoinositide phosphatases. Annu Rev Biochem 70:247-79
76. Mahadev K, Zilbering A, Zhu L, Goldstein BJ (2001) Insulin-stimulated hydrogen peroxide reversibly inhibits protein-Tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 276:21938-42
77. Majeti R, Bilwes AM, Noel JP, Hunter T, Weiss A (1998) Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279:88-91
78. McLean J, Batt J, Doering LC, Rotin D, Bain Jr. (2002) Enhanced rate of nerve regeneration and directional errors after sciatic nerve injury in receptor protein tyrosine phosphatase sigma knock-out mice. J Neurosci 22:5481-5491
79. Meng TC, Fukada T, Tonks NK (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9:387-399
80. Minassian BA, Lee JR, Herbrick J-A, Huizenga J, Soder S, Mungall AJ, Dunham I, Gardner R (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 20:171-174
81. Mok A, Cao H, Zinman B, Hanley AJ, Harris SB, Kennedy BP, Hegele RA (2002) A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree. J Clin Endocrinol Metab 87:724-7
82. Murli S, Watson RO, Galan JE (2001) Role of tyrosine kinases and the tyrosine phosphatase SptP in the interaction of Salmonella with host cells. Cell Microbiol 3:795-810
83. Nakamura M, Kishi M, Sakaki T, Hashimoto H, Nakase H, Shimada K, Ishida E, Konishi N (2003) Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas. Cancer Res 63:737-41
84. Nandan D, Yi T, Lopez M, Lai C, Reiner NE (2002) Leishmania EF-1alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J Biol Chem 277:50190-7
85. Nelson RL, Branton PE (1984) Identification, purification, and characterization of phosphotyrosine-specific protein phosphatases from cultured chicken embryo fibroblasts. Mol Cell Biol 4:1003-12
86. Nemecek ER, Matthews DC (2002) Antibody-based therapy of human leukemia. Curr Opin Hematol 9:316-21
87. Nilsson I, Hoffmann I (2000) Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res 4:107-114
88. Oka T, Ouchida M, Koyama M, Ogama Y, Takada S, Nakatani Y, Tanaka T, Yoshino T, Hayashi K, Ohara N, Kondo E, Takahashi K, Tsuchiyama J, Tanimoto M, Shimizu K, Akagi T (2002) Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. Cancer Res 62:6390-4
89. Ostman A, Bohmer FD (2001) Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol 11:258-66
90. Ouellet M, Barbeau B, Tremblay MJ (2003) Protein tyrosyl phosphatases in T cell activation: Implication for human immunodeficiency virus transcriptional activity. Prog Nucleic Acid Res Mol Biol 73:69-105
91. Pagel JM, Matthews DC, Appelbaum FR, Bernstein ID, Press OW (2002) The use of radioimmunoconjugates in stem cell transplantation. Bone Marrow Transplant 29:807-816
92. Pang T, Levine MM, Ivanoff B, Wain J, Finlay BB (1998) Typhoid fever-important issues still remain. Trends Microbiol 6:131-3
93. Pasquet JM, Dachary-Prigent J, Nurden AT (1998) Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen. Biochem J 333:591-599
94. Pestell KE, Ducruet AP, Wipf P, Lazo JS (2000) Small molecule inhibitors of dual specificity protein phosphatases. Oncogene 19:6607-6612
95. Ponniah S, Wang DZ, Lim KL, Pallen CJ (1999) Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn. Curr Biol 9:535-8
96. Raugei G, Ramponi G, Chiarugi P (2002) Low molecular weight protein tyrosine phosphatases: Small, but smart. Cell Mol Life Sci 59:941-9
97. Ren JM, Li PM, Zhang WR, Sweet LJ, Cline G, Shulman GI, Livingston JN, Goldstein BJ (1998) Transgenic mice deficient in the LAR protein-Tyrosine phosphatase exhibit profound defects in glucose homeostasis. Diabetes 47:493-7
98. Rock MT, Brooks WH, Roszman TL (1997) Calcium-dependent signaling pathways in T cells. Potential role of calpain, protein tyrosine phosphatase 1B, and p130Cas in integrin-mediated signaling events. J Biol Chem 272:33377-33383
99. Rondinone CM, Trevillyan JM, Clampit J, Gum RJ, Berg C, Kroeger P, Frost L, Zinker BA, Reilly R, Ulrich R, Butler M, Monia BP, Jirousek MR, Waring JF (2002) Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. Diabetes 51:2405-11
100. Rothenbacher D, Brenner H (2003) Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: Recent developments and future implications. Microbes Infect 5:693-703
101. Ruivenkamp CA, van Wezel T, Zanon C, Stassen AP, Vlcek C, Csikos T, Klous AM, Tripodis N, Perrakis A, Boerrigter L, Groot PC, Lindeman J, Mooi WJ, Meijjer GA, Scholten G, Dauwerse H, Paces V, van Zandwijk N, van Ommen GJ, Demant P (2002) Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 31:295-300
102. Saha S, Bardelli A, Buckhaults P, Velculescu VE, Rago C, St Croix B, Romans KE, Choti MA, Lengauer C, Kinzler KW, Vogelstein B (2001) A phosphatase associated with metastasis of colorectal cancer. Science 294:1343-1346
103. Sasaki T, Sasaki-Irie J, Penninger JM (2001) New insights into the transmembrane protein tyrosine phosphatase CD45. Int J Biochem Cell Biol 33:1041-6
104. Serratosa JM, Gomez-Garre P, Gallardo ME, Anta B, de Bernabe DB, Lindhout D, Augustijn PB, Tassinari CA, Malafosse RM, Topcu M, Grid D, Dravet C, Berkovic SF, de Cordoba SR (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet 8:345-352
105. Sparks JW, Brautigan DL (1986) Molecular basis for substrate specificity of protein kinases and phosphatases. Int J Biochem 18:497-504
106. Su J, Muranjan M, Sap J (1999) Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Curr Biol 9:505-11
107. Tabiti K, Smith DR, Goh HS, Pallen CJ (1995) Increased mRNA expression of the receptor-like protein tyrosine phosphatase alpha in late stage colon carcinomas. Cancer Lett 93:239-248
108. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, Van Der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465-468
109. Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, Van Der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD (2002) PTPN11 mutations in Noonan syndrome: Molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70:1555-1563
110. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hahlen K, Hasle H, Licht JD, Gelb BD (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148-50
111. Tchilian EZ, Wallace DL, Wells RS, Flower DR, Morgan G, Beverley PC (2001) A deletion in the gene encoding the CD45 antigen in a patient with SCID. J Immunol 166:1308-1313
112. Teixeira JE, Mann BJ (2002) Entamoeba histolytica-induced dephosphorylation in host cells. Infect Immun 70:1816-1823
113. Thomas ML (1999) The regulation of antigen-receptor signaling by protein tyrosine phosphatases: A hole in the story. Curr Opin Immunol 11:270-6
114. Thompson KM, Uetani N, Manitt C, Elchebly M, Tremblay ML, Kennedy TE (2003) Receptor protein tyrosine phosphatase sigma inhibits axonal regeneration and the rate of axon extension. Mol Cell Neurosci 23:681-692
115. Tonks NK, Neel BG (2001) Combinatorial control of the specificity of protein tyrosine phosphatases. Curr Opin Cell Biol 13:182-95
116. Tonks NK, Diltz CD, Fischer EH (1988a) Characterization of the major protein-Tyrosinephosphatases of human placenta. J Biol Chem 263:6731-7
117. Tonks NK, Diltz CD, Fischer EH (1988b) Purification of the major protein-Tyrosine-phosphatases of human placenta. J Biol Chem 263:6722-30
118. Uetani N, Kato K, Ogura H, Mizuno K, Kawano K, Mikoshiba K, Yakura H, Asano M, Iwakura Y (2000) Impaired learning with enhanced hippocampal long-Term potentiation in PTPdelta-deficient mice. Embo J 19:2775-85
119. Vogel A, Strassburg CP, Manns MP (2003) 77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: Evidence for a genetic link. Genes Immun 4:79-81
120. Wallace MJ, Batt J, Fladd CA, Henderson JT, Skarnes W, Rotin D (1999) Neuronal defects and posterior pituitary hypoplasia in mice lacking the receptor tyrosine phosphatase PTPsigma. Nat Genet 21:334-8
121. Wang J, Bixby JL (1999) Receptor tyrosine phosphatase-delta is a homophilic, neuritepromoting cell adhesion molecular for CNS neurons. Mol Cell Neurosci 14:370-84
122. Wiener JR, Hurteau JA, Kerns BJ, Whitaker RS, Conaway MR, Berchuck A, Bast RC Jr. (1994a) Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas. Am J Obstet Gynecol 170:1177-83
123. Wiener JR, Kerns BJ, Harvey EL, Conaway MR, Iglehart JD, Berchuck A, Bast RC Jr. (1994b) Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: Association with p185c-erbB-2 protein expression. J Natl Cancer Inst 86:372-8
124. Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, Lovett M (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11:961-9
125. Wishart MJ, Dixon JE (2002) PTEN and myotubularin phosphatases: From 3-phosphoinositide dephosphorylation to disease. Phosphatase and tensin homolog deleted on chromosome ten. Trends Cell Biol 12:579-85
126. Wu C, Sun M, Liu L, Zhou GW (2003) The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 306:1-12
127. Xie Y, Yeo TT, Zhang C, Yang T, Tisi MA, Massa SM, Longo FM (2001) The leukocyte common antigen-related protein tyrosine phosphatase receptor regulates regenerative neurite outgrowth in vivo. J Neurosci 21:5130-5138
128. Yang T, Bernabeu R, Xie Y, Zhang JS, Massa SM, Rempel HC, Longo FM (2003) Leukocyte antigen-related protein tyrosine phosphatase receptor: A small ectodomain isoform functions as a homophilic ligand and promotes neurite outgrowth. J Neurosci 23:3353-63
129. Yeo TT, Yang T, Massa SM, Zhang JS, Honkaniemi J, Butcher LL, Longo FM (1997) Deficient LAR expression decreases basal forebrain cholinergic neuronal size and hippocampal cholinergic innervation. J Neurosci Res 47:348-60
130. Zabolotny JM, Kim YB, Peroni OD, Kim JK, Pani MA, Boss O, Klaman LD, Kamatkar S, Shulman GI, Kahn BB, Neel BG (2001) Overexpression of the LAR (leukocyte antigen-related) protein-Tyrosine phosphatase in muscle causes insulin resistance. Proc Natl Acad Sci U S A 98:5187-92
131. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG (2002) PTP1B regulates leptin signal transduction in vivo. Dev Cell 2:489-95
132. Zeng Q, Dong JM, Guo K, Li J, Tan HX, Koh V, Pallen CJ, Manser E, Hong W (2003) PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res 63:2716-22
133. Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW (1993) Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res 53:2272-8
134. Zhang J, Somani AK, Siminovitch KA (2000) Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin Immunol 12:361-378
135. Zhang Z-Y (1998) Protein-Tyrosine phosphatases: Biological function, structural characteristics, and mechanism of catalysis. Crit Rev Biochem Mol Biol 33:1-52
136. Zhang Z-Y, Zhou B, Xie L (2002) Modulation of protein kinase signaling by protein phosphatases and inhibitors. Pharmacol Ther 93:307-317
137. Zheng XM, Wang Y, Pallen CJ (1992) Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Nature 359:336-9
138. Zheng XM, Resnick RJ, Shalloway D (2002) Mitotic activation of protein-Tyrosine phosphatase alpha and regulation of its Src-mediated transforming activity by its sites of protein kinase C phosphorylation. J Biol Chem 277:21922-21929
139. Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF (2002) PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci U S A 99:11357-11362